Rapport Therapeutics, Inc. · NASDAQ:RAPP
Third Rock Ventures V, L.P. sold 133,618 Rapport Therapeutics, Inc. shares (Form 4)
Traded May 11, 2026 · Filed May 13, 2026
On May 11, 2026, Third Rock Ventures V, L.P. (10% owner) sold 133,618 Rapport Therapeutics, Inc. shares at US$40.24 for US$5.38M under a trading plan, leaving 6,299,097 shares. Filed May 13, 2026 (Form 4).
- Sold
- 133,618 shares
- Price
- US$40.24
- Value
- US$5.38M
- Holding after
- 6,299,097 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | Sale | 133,618 | US$40.24 | 6,299,097 | Direct |
Source
Related
- Rapport Therapeutics, Inc.
- Third Rock Ventures V, L.P.
- Rapport Therapeutics, Inc. shareholders
- Form 4 · Third Rock Ventures V, L.P. · May 28, 2026
- Form 4 · Ceesay Abraham · Oct 8, 2026
- Form 4 · Gault Cheryl · Oct 1, 2026
- Form 4 · Ceesay Abraham · Sep 24, 2026
- Form 4 · Ceesay Abraham · Sep 9, 2026
- Form 4 · Ceesay Abraham · Aug 26, 2026